Chemoprevention by indomethacin of tumor promotion in a rat urinary bladder carcinogenesis model.
The chemopreventive effects of indomethacin (IM) on the enhancement of bladder carcinogenesis and transitional-epithelial-cell proliferation by butylated hydroxyanisole (BHA) or sodium L-ascorbate (Na-AsA) were investigated. All animals were given 0.05% N-butyl-N-(4-hydroxybutyl)nitrosamine (BBN) in their drinking water for 4 weeks. They then received 2% BHA or 5% Na-AsA for 20 weeks, followed by 20 ppm IM in the drinking water or normal tap water without supplement for a further 20 weeks, or BHA or Na-AsA alone or concomitantly with IM for 40 weeks. No differences in bladder-tumor development were found when IM was administered after cessation of BHA or Na-AsA exposure. However, IM in combination with either BHA or Na-AsA significantly reduced both the incidence and the multiplicity of papillomas and carcinomas as compared with the values of groups receiving BHA or Na-AsA alone. This was associated with decreased DNA synthesis and prostaglandin (PG) E2 levels in the existing bladder tumors. Combined treatment with IM did not exert any effects on BHA forestomach carcinogenesis. A separate 8-week combination study demonstrated that IM diminished the increase in expression of proliferation nuclear-cell antigen (PCNA) induced by BHA or Na-AsA alone. The present results suggest that PGE2 may be involved in promotion of rat bladder carcinogenesis and that the PG synthesis blocker IM might exert preventive effects on the development of bladder cancer in humans.
Shibata
M A
MA
First Department of Pathology, Nagoya City University Medical School, Japan.
Hasegawa
R
R
Shirai
T
T
Takesada
Y
Y
Fukushima
S
S
D000818:Animals; D001205:Ascorbic Acid; D002083:Butylated Hydroxyanisole; D002455:Cell Division / Q000187:drug effects; D015232:Dinoprostone / Q000378:metabolism; D004354:Drug Screening Assays, Antitumor; D006965:Hyperplasia / Q000139:chemically induced; D007213:Indomethacin / Q000494:pharmacology*; D008297:Male; D051381:Rats; D011916:Rats, Inbred F344; D013270:Stomach / Q000187:drug effects / Q000473:pathology; D001743:Urinary Bladder / Q000187:drug effects; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced / Q000378:metabolism / Q000473:pathology / Q000517:prevention & control*
D002083:Butylated Hydroxyanisole; D015232:Dinoprostone; D001205:Ascorbic Acid; D007213:Indomethacin